A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

I attended my high school reunion and had no anxiety about appearance,” Sarah gushed. “My new problem was graciously ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Eli Lillys Zepbound set to eclipse Wegovy in U.S. obesity drug market Eli Lillys new obesity drug poised to challenge ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for many people.

GLP-1 drugs — which include Ozempic and its sister drug Wegovy, as well as Mounjaro and Zepbound — mimic at least one hormone produced by the gut to signal fullness, leading to a reduced appetite.

This comes after both Maccabi and Meuhedet Health Services announced the same subsidy for the Mounjaro weight loss shot.

Professor Kamila Hawthorne, chairman of the Royal College of GPs, said she had 'serious concerns' about drugs sold by ...

A sign with the company logo stands in front of the Eli Lilly and Company headquarters campus in Indianapolis, Indiana, on March 17, 2024. New study data has solidified the club's position Eli Lillyis ...

Ozempic's ads were 57% more effective in driving consumer engagement on streaming TV than on linear TV during Q3.

Skyrocketing demand for Ozempic ( NVO ), Wegovy and other weight-loss drugs has boosted business for another line of work: ...